These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 23840511)
41. Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C. Sagnelli C; Merli M; Uberti-Foppa C; Hasson H; Cirillo G; Grandone A; Salpietro S; Minichini C; Del Giudice EM; Lazzarin A; Sagnelli E; Coppola N Clin Microbiol Infect; 2016 Apr; 22(4):372-378. PubMed ID: 26806136 [TBL] [Abstract][Full Text] [Related]
42. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070 [TBL] [Abstract][Full Text] [Related]
43. HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection. MacParland SA; Fadel SM; Mihajlovic V; Fawaz A; Kim C; Rahman AK; Liu J; Kaul R; Kovacs C; Grebely J; Dore GJ; Wong DK; Ostrowski MA PLoS One; 2016; 11(4):e0154433. PubMed ID: 27124305 [TBL] [Abstract][Full Text] [Related]
44. IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV-coinfected patients. Jiménez-Sousa MA; Berenguer J; Fernández-Rodríguez A; Micheloud D; Guzmán-Fulgencio M; Miralles P; Pineda-Tenor D; García-Álvarez M; López JC; Aldámiz-Echevarria T; Carrero A; Resino S J Viral Hepat; 2014 Mar; 21(3):189-97. PubMed ID: 24438680 [TBL] [Abstract][Full Text] [Related]
45. Gender differences in liver fibrosis and hepatitis C virus-related parameters in patients coinfected with human immunodeficiency virus. Collazos J; Cartón JA; Asensi V Curr HIV Res; 2011 Jul; 9(5):339-45. PubMed ID: 21827383 [TBL] [Abstract][Full Text] [Related]
46. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C. Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692 [TBL] [Abstract][Full Text] [Related]
47. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study. Desai SN; Dodge JL; Landay AL; Glesby MJ; Latham PS; Villacres MC; French AL; Gange SJ; Greenblatt RM; Peters MG Medicine (Baltimore); 2016 Aug; 95(33):e4483. PubMed ID: 27537569 [TBL] [Abstract][Full Text] [Related]
48. Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation. Montes-de-Oca M; Blanco MJ; Marquez M; Soto MJ; Fernandez-Gutiérrez C; Rodriguez-Ramos C; Giron-Gonzalez JA Liver Int; 2011 Jul; 31(6):850-8. PubMed ID: 21645216 [TBL] [Abstract][Full Text] [Related]
49. Toll-like receptor 8 (TLR8) polymorphisms are associated with non-progression of chronic hepatitis C in HIV/HCV coinfected patients. Fernández-Rodríguez A; Berenguer J; Jiménez-Sousa MA; García-Álvarez M; Aldámiz-Echevarría T; Pineda-Tenor D; Diez C; de la Barrera J; Bellon JM; Briz V; Resino S Infect Genet Evol; 2015 Dec; 36():339-344. PubMed ID: 26455634 [TBL] [Abstract][Full Text] [Related]
50. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study. Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449 [TBL] [Abstract][Full Text] [Related]
51. The absence of the human platelet antigen polymorphism effect on fibrosis progression in human immunodeficiency virus-1/hepatitis C virus coinfected patients. Picelli N; Tanikawa AA; Grotto RM; Silva GF; Barbosa AN; Ferrasi AC; Silveira LV; Pardini MI Rev Soc Bras Med Trop; 2015; 48(4):406-9. PubMed ID: 26312929 [TBL] [Abstract][Full Text] [Related]
52. IL-28B genetic variation, gender, age, jaundice, hepatitis C virus genotype, and hepatitis B virus and HIV co-infection in spontaneous clearance of hepatitis C virus. Fedorchenko SV; Klimenko A; Martynovich T; Liashok O; Yanchenko V Turk J Gastroenterol; 2019 May; 30(5):436-444. PubMed ID: 31060998 [TBL] [Abstract][Full Text] [Related]
53. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy? Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Moll A; Jäger H; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK HIV Med; 2018 Apr; 19(4):299-307. PubMed ID: 29368456 [TBL] [Abstract][Full Text] [Related]
54. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262). Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M PLoS One; 2016; 11(5):e0153744. PubMed ID: 27148964 [TBL] [Abstract][Full Text] [Related]
55. Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus-Related Liver Cirrhosis Risk. Sheneef A; Esmat MM; Mohammad AN; Mahmoud AA; Moghazy HM; Noureldin AK J Interferon Cytokine Res; 2017 Apr; 37(4):175-180. PubMed ID: 28387594 [TBL] [Abstract][Full Text] [Related]
56. Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients. Miailhes P; Gilbert C; Lacombe K; Arends JE; Puoti M; Rockstroh JK; Sogni P; Fontaine H; Rosenthal E; Winnock M; Loko MA; Wittkop L; Dabis F; Salmon D; Liver Int; 2015 Sep; 35(9):2090-9. PubMed ID: 25650873 [TBL] [Abstract][Full Text] [Related]
57. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Mangia A; Santoro R; Piattelli M; Pazienza V; Grifa G; Iacobellis A; Andriulli A Cytokine; 2004 Feb; 25(3):103-9. PubMed ID: 14698136 [TBL] [Abstract][Full Text] [Related]
58. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy. Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390 [TBL] [Abstract][Full Text] [Related]
59. Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients. Nattermann J; Vogel M; Berg T; Danta M; Axel B; Mayr C; Bruno R; Tural C; Klausen G; Clotet B; Lutz T; Grünhage F; Rausch M; Nischalke HD; Schewe K; Bienek B; Haerter G; Sauerbruch T; Rockstroh JK; Spengler U; Hepatology; 2007 Oct; 46(4):1016-25. PubMed ID: 17668881 [TBL] [Abstract][Full Text] [Related]
60. TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype. Sagnelli C; Merli M; Uberti-Foppa C; Hasson H; Grandone A; Cirillo G; Salpietro S; Minichini C; Starace M; Messina E; Morelli P; Miraglia Del Giudice E; Lazzarin A; Coppola N; Sagnelli E World J Gastroenterol; 2016 Oct; 22(38):8509-8518. PubMed ID: 27784963 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]